Managing High-Risk Breast Cancer
نویسندگان
چکیده
منابع مشابه
Managing Breast Cancer Risk
Twenty years ago there was little interest in defining personal breast cancer risk or insight into what to offer women at high risk of breast cancer. This situation has changed markedly, partly because of the discovery of the importance of mutations in predisposing genes for breast cancer and partly because of the growing realisation that there were management options that might reduce the risk...
متن کاملBreast Cancer: Risk Factors, Diagnosis and Management
ABSTRACT Breast cancer remains the most common cancer of women and one of the most common causes of cancer-related deaths worldwide. In spite of major advances in breast cancer diagnosis and treatment, the incidence of breast cancer remains high and the treatment of metastatic breast cancer remains challenging. This review presents an over...
متن کاملBreast Cancer Screening in High-Risk Women
Women who are at a significantly raised risk of developing breast cancer should be assessed by a medical geneticist to confirm their history, counselled as to appropriate management and offered breast screening. Currently mammography with magnetic resonance imaging is considered the optimal method of early detection of breast cancer in these women. While there is no evidence of mortality benefi...
متن کامل[Breast cancer screening in high risk populations].
We aim to define which patients make up the populations with high and intermediate risk of developing breast cancer, to review the studies of screening with magnetic resonance imaging in addition to mammography in high risk patients (describing the imaging characteristics of the cancers in this group), to review the studies of screening with magnetic resonance imaging in patients with intermedi...
متن کاملManaging the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that has antiestrogenic effects on breast and endometrial tissue and estrogenic effects on bone, lipid metabolism, and blood clotting. Raloxifene significantly improves serum lipids and serum markers of cardiovascular disease risk, but it has no significant effect on the risk of primary coronary events. A meta-analysis o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Oncology Nursing
سال: 2007
ISSN: 0749-2081
DOI: 10.1016/j.soncn.2006.11.005